Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Accumulated Expenses (2016 - 2025)

Surgery Partners' Accumulated Expenses history spans 12 years, with the latest figure at $64.9 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 7.45% year-over-year to $64.9 million; the TTM value through Dec 2025 reached $64.9 million, up 7.45%, while the annual FY2025 figure was $64.9 million, 7.45% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $64.9 million at Surgery Partners, down from $69.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $83.8 million in Q1 2022 and bottomed at $59.3 million in Q2 2025.
  • The 5-year median for Accumulated Expenses is $68.8 million (2022), against an average of $70.3 million.
  • The largest annual shift saw Accumulated Expenses soared 62.95% in 2021 before it decreased 23.27% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $77.1 million in 2021, then decreased by 10.64% to $68.9 million in 2022, then increased by 7.11% to $73.8 million in 2023, then decreased by 18.16% to $60.4 million in 2024, then grew by 7.45% to $64.9 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Accumulated Expenses are $64.9 million (Q4 2025), $69.9 million (Q3 2025), and $59.3 million (Q2 2025).